Vaishali Pharma Board of Directors

Get the latest insights into the leadership at Vaishali Pharma. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Vishwa MekhiaCompany Secretary & Compliance Officer
Atul VasaniManaging Director
Pratik JakheliaNon Executive Independent Director
Manish Bhagwandas VedNon Executive Independent Director
Dewansh VasaniExecutive Director & Chief Financial Officer
Jagruti Atul VasaniWhole Time Director
Bhavesh Kumar UpadhyayNon Independent & Non Executive Director

Vaishali Pharma Share price

VAISHALI

8.03

0 (0.00%)
Last updated on 24 Apr, 2026 | 15:53 IST
Today's High

8.43

Today's Low

7.88

52 Week Low

0.00

52 Week High

8.43

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Vaishali Pharma FAQs

The board at Vaishali Pharma consists of experienced professionals, including Vishwa Mekhia, Atul Vasani, and others, overseeing the company’s strategic and corporate governance.

Directors at Vaishali Pharma are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Vishwa Mekhia is the current chairman at Vaishali Pharma.

Executive directors at Vaishali Pharma are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Vaishali Pharma adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Vaishali Pharma, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost